Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Intelligent
Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful
exhibition of its Intelligent Fingerprinting Drug Screening Solution at The Health & Safety Event 2024, the United Kingdom’s largest annual technology showcase exhibiting products and services
that strengthen and support workplace safety standards. According to the event website, this year's event welcomed over 250+ industry-leading exhibitors and over 11,500 attendees, including
visitors from major brands such as Amazon, PepsiCo, Rolls Royce, Jaguar Land Rover, and Harvey Nichols.
The Health & Safety Event has become a crucial meeting place for individuals dedicated to maintaining safe and efficient workplaces. It served as a prominent stage for INBS to demonstrate its innovative drug screening technology. According to the event website, 77% of those who attend the show are key decision-makers, with 88% considering the show essential to their business operations.
During the event Company representatives facilitated live demonstrations with the participation of notable clients such as Stewart Osmond, Haulage & Logistics Director at WTW (Willis Towers Watson). Mr. Osmond discussed the company's collaborative efforts in combating the under-addressed risk of drug driving within the logistics sector, highlighting how the Intelligent Fingerprinting solution has been pivotal in enhancing fleet safety and compliance.
Additionally, the Company engaged in discussions with its South American distributor about its initial steps towards a pilot program aimed at integrating the Intelligent Fingerprinting technology into hospitals and emergency services in Chile. This prospective expansion reflects the global relevance and versatility of the fingerprint-based drug screening solution.
Lesen Sie auch
Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions, commented, “This year's Health & Safety Event marks our most successful yet. The surge in interest and engagement from industry leaders and decision-makers validate the effectiveness and necessity of our drug screening solution and reflects the growing commitment across sectors to ensure a safer workplace environment. Our presence at the event has significantly broadened our reach and deepened our impact, facilitating key discussions and opportunities that will drive the future of workplace safety innovations.”